https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2354/brightline-2-phase-iiaiib-open-label/?section=elg&qd=31957105
Brightline-2: A Phase IIa/IIb open-label single-arm multi-centre trial of brigimadlin (BI 907828)...
New life-saving treatments for MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours...